<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2013.41006</article-id><article-id pub-id-type="publisher-id">IJCM-26897</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  &lt;i&gt;SAP&lt;/i&gt; Expression in &lt;i&gt;Candida albicans&lt;/i&gt; Strains Isolated from Mexican Patients with Vaginal Candidosis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ric</surname><given-names>Monroy-Pérez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gloria</surname><given-names>Paniagua-Contreras</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Felipe</surname><given-names>Vaca-Paniagua</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erasmo</surname><given-names>Negrete-Abascal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sergio</surname><given-names>Vaca</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Laboratorio de Genómica,?Instituto Nacional de Cancerología, México, DF, México </addr-line></aff><aff id="aff1"><addr-line>FES-Iztacala, Universidad Nacional Autónoma de México, México, DF, México</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>vacasergio@gmail.com(SV)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>01</month><year>2013</year></pub-date><volume>04</volume><issue>01</issue><fpage>25</fpage><lpage>31</lpage><history><date date-type="received"><day>November</day>	<month>20th,</month>	<year>2012</year></date><date date-type="rev-recd"><day>December</day>	<month>27th,</month>	<year>2012</year>	</date><date date-type="accepted"><day>January</day>	<month>8th,</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   To determine the frequency and expression of the ten SAP (secreted aspartyl protease) genes in a group of Candida albicans strains isolated from Mexican women suffering from vaginal candidosis, a group of 264 women (age 18 - 57 years) with vaginal infections, predisposed by diabetes mellitus or contraceptive consumption, were evaluated. C. albicans was identified using PCR to amplify the rRNA internal transcribed spacer regions ITS1 and ITS2. The presence of the SAP genes was determined using conventional PCR, and their expression levels were determined using real-time PCR after the C. albicans strains had been grown in reconstituted human vaginal epithelium (RHVE). C. albicans was identified in the samples from 50 women (18.9%). The genotyping frequencies of the SAP genes were as follows: SAP1, 94%; SAP2, 98%; SAP3, 80%; SAP4, 100%; SAP5, 100%; SAP6, 100%; SAP7, 63%; SAP8, 96%; SAP9, 70%; and SAP10, 88%. The most frequently expressed genes in the strains harboring all of the genes were SAP1, 90%; SAP2, 90%; SAP3, 90%; SAP4, 100%; SAP5, 90%; SAP6, 90%; SAP7, 100%; SAP8, 90%; SAP9, 100%; and SAP10, 100%. SAP genes were expressed in the RHVE, suggesting that the Sap proteins play an important role in the pathogenesis of infection. 
 
</p></abstract><kwd-group><kwd>Candida albicans; RHVE; &lt;i&gt;SAP&lt;/i&gt; Expression</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Candida albicans are classified as commensal fungi that inhabit the human gastrointestinal tract. It grows as round cells in smooth, white colonies. Additionally, C. albicans can cause oral and vaginal infections as well as systemic diseases [<xref ref-type="bibr" rid="scirp.26897-ref1">1</xref>].<sup> </sup>Vaginal candidosis (VC) is one of the most common infections that afflicts women of reproductive age [2,3]. Approximately 75% of women will experience at least one episode of VC during their lives [3,4]. C. albicans possesses several virulence factors that are involved in hyphae formation [<xref ref-type="bibr" rid="scirp.26897-ref5">5</xref>], phenotype switching [6-8], cell adhesion [9-12], and extracellular production of hydrolytic enzymes [13,14]. Secreted aspartyl proteases (Saps) are enzymes that are secreted by C. albicans and are coded for by the SAP gene family (SAP1-SAP10) [<xref ref-type="bibr" rid="scirp.26897-ref15">15</xref>]. The proteolytic activity of the Sap proteins is involved in the degradation of the host’s barriers during infection [<xref ref-type="bibr" rid="scirp.26897-ref16">16</xref>], immune response evasion [<xref ref-type="bibr" rid="scirp.26897-ref17">17</xref>], and adhesion to the host’s cells [<xref ref-type="bibr" rid="scirp.26897-ref18">18</xref>]. This family of proteases can be differentially expressed and regulated under a variety of growth conditions in the laboratory [19,20], such as during experimental infections using reconstituted human oral epithelium (RHE) [<xref ref-type="bibr" rid="scirp.26897-ref21">21</xref>], or in vivo [<xref ref-type="bibr" rid="scirp.26897-ref22">22</xref>].</p><p>Different SAP genes appear to be essential for mucosal (SAP1-SAP3) [23,24], and systemic infections (SAP4- SAP6) [<xref ref-type="bibr" rid="scirp.26897-ref25">25</xref>]. The expression and importance of SAP1, SAP2, SAP3 during murine vaginal candidiasis were also demonstrated by using RT-PCR and SAP-deficient mutants [25-27]. It is not clear whether the murine model is representative of proteinase expression during human vaginal infection.</p><p>The purpose of this work was to use a reconstituted human vaginal epithelium (RHVE) model to determine the frequency and expression of the ten SAP genes in C. albicans strains that had been isolated from women with VC.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Patients and Samples</title><p>Procedures followed in this study were in accordance with the Ethical Committee of each hospital.</p><p>This study included 264 women who presented with vulvovaginitis-associated symptoms, such as burning, itching, dysuria, and curd-like discharge; these women visited gynecologic services at public hospitals located in the State of Mexico, Mexico. The age range of the women in this study was between 18 and 57 years. Patients presenting with cervical cancer, pregnancy, or who had undergone antibiotic or antimycotic treatments within the last 30 days were excluded from the study. After obtaining informed consent from each patient, two samples were taken from the vaginal cavity using sterile cotton swabs. One of these samples was used to confirm the presence of pseudohyphae or hyphae by direct examination under a microscope. The second sample was used to inoculate brain hearth infusion (BHI) culture media (BD Bioxon, Cuatitl&#225;n Izcalli, State of Mexico, Mexico), and the cultures were then incubated at 37˚C for 24 hours. After 24 hours, the cultures were plated on Sabouraud Agar (BD Bioxon, Cuatitlan Izcalli, State of Mexico, Mexico) containing 50 &#181;g/ml chloramphenicol and were incubated at 37˚C for 72 hours.</p></sec><sec id="s2_2"><title>2.2. Identification of C. albicans</title><p>Samples were collected from the pure cultures grown in Sabouraud Agar and were identified by colony and microscopic morphologies and using a germ tube test in BHI that was supplemented with 10% horse serum and the API 20 C AUX system (BioMerieux, Durham, NC, USA). The C. albicans ATCC32354 strain was used as a positive control.</p><p>C. albicans was also identified using PCR by amplifying the internal transcribed spacers (ITS1 and ITS2) from the rRNA gene [<xref ref-type="bibr" rid="scirp.26897-ref28">28</xref>]. C. albicans genomic DNA was extracted using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA). PCR amplification was performed in a Corbette Research Thermocycler using PuReTaq Ready-To-Go PCR Beads (GE Healthcare, Piscataway, New Jersey, USA). The amplicons were stained with ethidium bromide after electrophoresis in a 2% agarose gel and were visualized with UV illumination using a GEL LOGIC 100 (KODAK). The C. albicans ATCC32354 strain was used as a positive control.</p></sec><sec id="s2_3"><title>2.3. PCR Amplification of C. albicans SAP Genes</title><p>The primers and amplification conditions for SAP1 were described by Hube et al. [<xref ref-type="bibr" rid="scirp.26897-ref29">29</xref>], SAP2 by Wright et al. [<xref ref-type="bibr" rid="scirp.26897-ref30">30</xref>], SAP3 by White et al. [<xref ref-type="bibr" rid="scirp.26897-ref31">31</xref>], SAP4-SAP6 and SAP8 by Naglik et al. [<xref ref-type="bibr" rid="scirp.26897-ref22">22</xref>], SAP7 by Monod et al. [<xref ref-type="bibr" rid="scirp.26897-ref32">32</xref>], and SAP9 and SAP10 by Naglik et al. [<xref ref-type="bibr" rid="scirp.26897-ref33">33</xref>] (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p><xref ref-type="table" rid="table1">Table 1</xref>. Primers used in PCR and real time PCR assays.</p><p><img src="6-2100454\37bbb202-a789-4cd6-b25f-2a3f1badbbe0.jpg" /></p></sec><sec id="s2_4"><title>2.4. RHVE Inoculation with C. albicans</title><p>Both C. albicans strains tested positive for the expression of all of the SAP genes, and the control strains were grown as described by Schaller et al. [16,21]. The C. albicans ATCC32354 strain was used as a positive control. The following strains from our collection, which are each missing one SAP gene, were used as negative controls: C. albicans 4, C. albicans 7, C. albicans 22, Staphylococcus epidermidis ATCC35984, C. albicans 27, C. albicans 50, and C. albicans 28. A total of 2 &#215; 10<sup>6</sup> C. albicans cells suspended in 50 &#181;l of PBS were inoculated onto the surface of the RHVE A431 (SkinEthic Laboratory, Nice, France) and were incubated at 37˚C for 72 hours with 5% CO<sub>2</sub> and saturated humidity. The maintenance media was changed every 24 hours.</p></sec><sec id="s2_5"><title>2.5. C. albicans RNA Purification and Reverse Transcription</title><p>C. albicans cells were harvested from the RHVE, suspended in 200 &#181;l of Y1 buffer containing lyticase (50 U/10<sup>7</sup> cells), and incubated at 30˚C for 20 minutes using gentle shaking to facilitate the formation of spheroplasts. The extraction and purification of the total RNA was performed using an RNeasy MiniKit (Qiagen, Hilden, Germany). The RNA concentration and purity were determined using a Nanodrop 2000 spectrophotometer. To obtain cDNA, a QuantiTec Reverse transcription kit (Qiagen) was used according to the manufacturer’s instructions.</p></sec><sec id="s2_6"><title>2.6. Real-Time PCR Amplification of the SAP Genes</title><p>The SAP primers that were used for the endpoint PCR were also used for the real-time PCR assay (<xref ref-type="table" rid="table1">Table 1</xref>). The Rotor-Gene SYBR Green PCR kit (Qiagen) was used for the real-time PCR experiments. A final volume of 25 &#181;l was used for each reaction and contained 12.5 &#181;l of SYBR Green Master Mix, 1 &#181;l of forward primer (1 &#181;m), 1 &#181;l of reverse primer (1 &#181;m), 2 &#181;l of cDNA (20 ng), and 8.5 &#181;l of RNase-free water. The amplification conditions were 95˚C for 5 minutes followed by 95˚C for 5 seconds with an annealing/extension combination step at 60˚C for 10 seconds for 40 cycles. The same positive and negative controls that were used for the endpoint PCR experiments were also used for the real-time PCR assay.</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>The frequency of the SAP family genes among the C. albicans strains isolated from women within the age ranges of 18 - 29 (n = 13), 29 - 39 (n = 14), 40 - 49 (n = 11), and 50 - 57 (n = 12) years were analyzed using the c<sup>2 </sup>test with a significance threshold of P &lt; 0.005.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. C. albicans Positive Samples</title><p>Infection with C. albicans was determined using microbiologic criteria and by PCR. The ITS were amplified from 18.9% (n = 50) of the vaginal samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Detection and Association of SAP Genotypes in C. albicans Strains</title><p>The SAP4, SAP5, SAP6, SAP2, SAP8, SAP1, and SAP10 genes were detected at a higher frequency in C. albicans strains than were the SAP9, SAP3, and SAP7 genes (<xref ref-type="table" rid="table2">Table 2</xref>). There were no statistically significant differences among the SAP genotype frequencies in the C. albicans strains isolated from women in the age ranges of 18 - 29 (n = 13), 29 - 39 (n = 14), 40 - 49 (n = 11), and 50 - 57 (n = 12) years (threshold of P &lt; 0.005).</p><p>Sixteen different association patterns of SAP genes were found among these strains (<xref ref-type="table" rid="table3">Table 3</xref>). Twenty strains carried all of the studied SAP genes, and ten of the strains had only nine of the SAP genes (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p><xref ref-type="table" rid="table2">Table 2</xref>. Frequency of the SAP genes and their expression in Candida albicans strains.</p><p><img src="6-2100454\1469a560-552b-4bda-bc2b-30a734a52607.jpg" /></p><p><xref ref-type="table" rid="table3">Table 3</xref>. Detected SAP genotypes in Candida albicans strains.</p><p><img src="6-2100454\82a11112-8fa1-4866-a2ea-951ddfad22c7.jpg" /></p></sec><sec id="s3_3"><title>3.3. SAP Gene Expression Determined by Real-Time PCR</title><p>To determine the SAP virulence markers, 11 clinical strains carrying all of the SAP genes (Pattern 1, <xref ref-type="table" rid="table3">Table 3</xref>) were inoculated onto RHVE and were then analyzed using real-time PCR. The Tm was recorded for each realtime assay to differentiate specific from non-specific PCR products (data not shown). Constitutive rRNA expression was used as a control (data not shown). All of the SAP genes were expressed. The genes SAP4, SAP7, SAP9, and SAP10 were expressed in 100% of the isolated C. albicans strains, whereas SAP1, SAP2, SAP3, SAP5, SAP6, and SAP8 were expressed in 90% of the strains (<xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Candida albicans was identified in vaginal samples of 18.9% (n = 50) of the women in this study. This result is in agreement with previously reported frequencies for VC, which occurs in 20% - 25% of infectious vaginitis cases, which is just below the 40% - 50% of cases that develop bacterial vaginitis [<xref ref-type="bibr" rid="scirp.26897-ref4">4</xref>]. Among Mexican women, VC is the ninth most common cause of disease (incidence of 529 in 100,000 women; SUIVE/DGE/Ministry of Health/United Mexican States-2008). Candidosis is</p><p>not common during puberty; however, by 25 years of age, 50% of women have had at least one clinically diagnosed VC episode [34,35]. C. albicans causes 85% - 95% of VC cases [4,36]. External factors that predispose patients to VC are pregnancy, the use of oral contraceptives, diabetes mellitus, and antibiotics usage [3,37].</p><p>The high frequency of SAP genes (<xref ref-type="table" rid="table2">Table 2</xref>) and the high number of association patterns in C. albicans strains (<xref ref-type="table" rid="table3">Table 3</xref>) suggest that multiple Sap expression profiles exist during VC pathogenesis. For example, the SAP4- SAP6 genes, which were present in all of the analyzed C. albicans strains (Table2), are associated with hyphae formation. In addition to being involved in cell adhesion, hyphae can penetrate individual cells or intercellular spaces [<xref ref-type="bibr" rid="scirp.26897-ref38">38</xref>]. The Sap2 protein, which was detected in 98% of the studied strains (Table2), can degrade many human proteins, including those that protect the mucosal surfaces, such as mucine [39,40] and secretory immunoglobulin A (sIgA) [<xref ref-type="bibr" rid="scirp.26897-ref41">41</xref>], and molecules from the extracellular matrix, such as keratin, collagen, and vimentin [42- 44]. The ability of Sap2 to degrade these proteins may facilitate the dissemination of C. albicans throughout the circulatory system [<xref ref-type="bibr" rid="scirp.26897-ref45">45</xref>].</p><p>In this study the genes SAP4, SAP7, SAP9, and SAP10 were expressed in 100% of the isolated C. albicans strains, whereas SAP1, SAP2, SAP3, SAP5, SAP6, and SAP8 were expressed in 90% of the strains (<xref ref-type="table" rid="table2">Table 2</xref>). Similar data were described by Schaller et al. [<xref ref-type="bibr" rid="scirp.26897-ref46">46</xref>], who used an in vitro candidosis RHVE model. In their study, the genes that were most frequently expressed during the late infection stage were SAP1, SAP2, SAP4, SAP7, SAP9, and SAP10, whereas in studies performed on vaginal infections in vivo, the most frequently expressed genes were SAP1, SAP3, and SAP6-SAP8 [<xref ref-type="bibr" rid="scirp.26897-ref22">22</xref>]. In vulvovaginal candidosis (VVC) and recurrent vulvovaginal candidosis (RVVC), the expression of SAP2 and SAP4- SAP7 [<xref ref-type="bibr" rid="scirp.26897-ref47">47</xref>] was reported. It has been suggested that the SAP4-SAP6 genes, which are frequently expressed in vaginal infection samples, play an important role in the evasion of the immune response during the active infection stage, which partially protects C. albicans from macrophage phagocytosis [<xref ref-type="bibr" rid="scirp.26897-ref17">17</xref>]. It has also been reported that the expression of the SAP4-SAP6 genes is associated with hyphae development in vitro [<xref ref-type="bibr" rid="scirp.26897-ref48">48</xref>], which suggests that Sap4-Sap6 production in the vaginal lumen enables C. albicans to attach to the vaginal mucosa.</p><p>Results presented in this study showed that all of the SAP genes were expressed in the RHVE, suggesting that the Sap proteins play an important role in the pathogenesis of infection.</p></sec><sec id="s5"><title>5. Acknowledgements</title><p>This work was supported by the grant PAPIME PE200209 from Universidad Nacional Aut&#243;noma de M&#233;xico.</p></sec><sec id="s6"><title>REFERENCES</title></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.26897-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">F. C. Odds, N. A. R. Gow and A. J. P. Brown, “Towards a Molecular Understanding of Candida albicans Virulence,” In: J. Heitman, S. G. Filler, J. E. Edwards Jr and A. P. Mitchell, Eds. Molecular Principles of Fungal Patho-genicity, ASM Press, Washington, 2006, pp. 305-319.</mixed-citation></ref><ref id="scirp.26897-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">B. Foxman, J. V. Marsh, B. Gillespie and J. D. Sobel, “Frequency and Response to Vaginal Symptoms among White and African American Women: Results of a Random Digit Dialing Survey,” Journal Women’s Health, Vol. 7, No. 9, 1998, pp. 1167-1174.  
doi:10.1089/jwh.1998.7.1167</mixed-citation></ref><ref id="scirp.26897-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, S. Faro, R. W. Force, B. Foxman, W. J. Ledger, P. R. Nyirsejy, B. D. Reed and P. R. Summers, “Vulvovaginal Candidiasis: Epidemiologic, Diagnostic, and Therapeutic Considerations,” American Journal of Obstetricts and Gynecology, Vol. 178, No. 2, 1998, pp. 203-211. doi:10.1016/S0002-9378(98)80001-X</mixed-citation></ref><ref id="scirp.26897-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, “Vaginitis,” New England Journal of Medicine, Vol. 337, No. 26, 1997, pp. 1896-1903. 
doi:10.1056/NEJM199712253372607</mixed-citation></ref><ref id="scirp.26897-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, G. Muller and H. R. Buckley, “Critical Role of Germ Tube Formation in the Pathogenesis of Candidal Vaginitis,” Infection and Immunity, Vol. 44, No. 3, 1984, pp. 576-580.</mixed-citation></ref><ref id="scirp.26897-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">D. R. Soll, C. J. Langtimm, J. McDowell, J. Hicks and R. Galask, “High-Frequency Switching in Candida Strains Isolated from Vaginitis Patients,” Journal of Clinical Microbiology, Vol. 25, No. 9, 1987, pp. 1611-1622.</mixed-citation></ref><ref id="scirp.26897-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">J. Hellstein, H. Vawter-Hugart, P. Fotos, J. Schmid and D. R. Soll, “Genetic Similarity and Phenotypic Diversity of Commensal and Pathogenic Strains of Candida albicans Isolated from the Oral Cavity,” Journal of Clinical Microbiology, Vol. 31, No. 12, 1993, pp. 3190-3199.</mixed-citation></ref><ref id="scirp.26897-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">K. Vargas, S. A. Messer, M. Pfaller, S. R. Lockhart, J. T. Stapleton, J. Hellstein and D. R. Soll, “Elevated Phenotypic Switching and Drug Resistance of Candida albicans from Human Immunodeficiency Virus-Positive Individuals Prior to First Thrush Episode,” Journal of Clinical Microbiology, Vol. 38, No. 10, 2000, pp. 3595-3607.</mixed-citation></ref><ref id="scirp.26897-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">N. K. Gaur and S. A. Klotz, “Expression, Cloning, and Characterization of a Candida albicans Gene, ALA1, That Confers Adherence Properties upon Saccharomyces cerevisiae for Extracellular Matrix Proteins,” Infection and Immunity, Vol. 65, No. 12, 1997, pp. 5289-5294.</mixed-citation></ref><ref id="scirp.26897-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">L. L. Hoyer and J. E. Hecht, “The ALS5 Gene of Candida albicans and Analysis of the Als5p N-Terminal Domain,” Yeast, Vol. 18, No. 1, 2001, pp. 49-60. 
doi:10.1002/1097-0061(200101)18:1&lt;49::AID-YEA646&gt;3.0.CO;2-M</mixed-citation></ref><ref id="scirp.26897-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">X. Zhao, C. Pujol, D. R. Soll and L. L. Hoyer, “Allelic Variation in the Contiguous Loci Encoding Candida albicans ALS5, ALS1 and ALS9,” Microbiology, Vol. 149, No. 10, 2003, pp. 2947-2960. doi:10.1099/mic.0.26495-0</mixed-citation></ref><ref id="scirp.26897-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">X. Zhao, S. H. Oh, G. Cheng, C. B. Green, J. A. Nuessen, K. Yeater, R. P. Leng, A. J. Brown and L. L. Hoyyer, “ALS3 and ALS8 Represent a Single Locus That Encodes a Candida albicans Adhesin; Functional Comparisons between Als3p and Als1p,” Microbiology, Vol. 150, No. 7, 2004, pp. 2415-2428. doi:10.1099/mic.0.26943-0</mixed-citation></ref><ref id="scirp.26897-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">B. Hube, “Possible Role of Secreted Proteinases in Candida albicans Infection,” Revista Iberoamericana de Micologia, Vol. 15, No. 2, 1998, pp. 65-68.</mixed-citation></ref><ref id="scirp.26897-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">M. A. Ghannoum, “Potential Role of Phospholipases in Virulence and Fungal Pathogenesis,” Clinical Microbiology Reviews, Vol. 13, No. 1, 2000, pp. 122-143. 
doi:10.1128/CMR.13.1.122-143.2000</mixed-citation></ref><ref id="scirp.26897-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">B. Hube and J. Naglik, “Candida albicans Proteinases: Resolving the Mystery of a Gene Family,” Microbiology, Vol. 147, No. 8, 2001, pp. 1997-2005.</mixed-citation></ref><ref id="scirp.26897-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">M. Schaller, H. C. Korting, W. Schafer, J. Bastert, W. Chen and B. Hube, “Secreted Aspartic Proteinase (Sap) Activity Contributes to Tissue Damage in a Model of Human Oral Candidiasis,” Molecular Microbiology, Vol. 34, No. 1, 1999, pp. 169-180.  
doi:10.1046/j.1365-2958.1999.01590.x</mixed-citation></ref><ref id="scirp.26897-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">M. Borgvon Zepelin, S. Beggah, K. Boggian, D. Sanglard and M. Monod, “The Expression of the Secreted Aspartyl Proteinases Sap4 to Sap6 from Candida albicans in Murine Macrophages,” Molecular Microbiology, Vol. 28, No. 3, 1998, pp. 543-554.  
doi:10.1046/j.1365-2958.1998.00815.x</mixed-citation></ref><ref id="scirp.26897-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">M. Borgvon Zepelin, I. Meyer, R. Thomssen, R. Würzner, D. Sanglard, A. Telenti and M. Monod, “HIV-Protease Inhibitors Reduce Cell Adherence of Candida albicans Strains by Inhibition of Yeast Secreted Aspartic Proteases,” The Journal of investigative dermatology, Vol. 113, No. 5, 1999, pp.747-751. 
doi:10.1046/j.1523-1747.1999.00747.x</mixed-citation></ref><ref id="scirp.26897-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">T. C. White and N. Agabian, “Candida albicans Secreted Aspartyl Proteinases: Isoenzyme Pattern Is Determined by Cell Type, and Levels Are Determined by Environmental Factors,” Journal of Bacteriology, Vol. 177, No. 18, 1995, pp. 5215-5221.</mixed-citation></ref><ref id="scirp.26897-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">B. Hube, M. Monod, D. A. Schofield, A. J. P. Brown and N. A. R. Gow, “Expression of Seven Members of the Gene Family Encoding Secretory Aspartyl Proteinases in Candida albicans,” Molecular Microbiology, Vol. 14, No. 1, 1994, pp. 87-99.  
doi:10.1111/j.1365-2958.1994.tb01269.x</mixed-citation></ref><ref id="scirp.26897-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">M. Schaller, W. Schafer, H. C. Korting and B. Hube, “Differential Expression of Secreted Aspartyl Proteinases in a Model of Human Oral Candidiasis and in Patient Samples from the Oral Cavity,” Molecular Microbiology, Vol. 29, No. 2, 1998, pp. 605-615. 
doi:10.1046/j.1365-2958.1998.00957.x</mixed-citation></ref><ref id="scirp.26897-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">J. R. Naglik, C. A. Rodgers, P. J. Shirlaw. J. L. Dobbie, L. L. Fernandes-Naglik, D. Greenspan, N. Agabian and S. J. Challacombe, “Differential Expression of Candida albicans Secreted Aspartyl Proteinase and Phospholipase B Genes in Humans Correlates with Active Oral and Vaginal Infections,” Journal of Infectious Diseases, Vol. 188, No. 3, 2003, pp. 465-475.</mixed-citation></ref><ref id="scirp.26897-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">F. De Bernardis, S. Arancia, L. Morelli, B. Hube, D. Sanglard, W. Schafer and A. Cassone, “Evidence That Members of the Secretory Aspartyl Proteinase Gene Family, In Particular SAP2, Are Virulence Factors for Candida Vaginitis,” Journal of Infectious Diseases, Vol. 179, No. 1, 1999, pp. 201-208. doi:10.1086/314546</mixed-citation></ref><ref id="scirp.26897-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">F. De Bernardis, A. Cassone, J. Sturtevant and R. Calderone, “Expression of Candida albicans SAP1 and SAP2 in Experimental Vaginitis,” Infection and Immunity, Vol. 63, No. 5, 1995, pp. 1887-1892.</mixed-citation></ref><ref id="scirp.26897-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">D. Sanglard, B. Hube, M. Monod, F. C. Odds, and N. A. Gow, “A Triple Deletion of the Secreted Aspartyl Proteinase Genes SAP4, SAP5, and SAP6 of Candida albicans Causes Attenuated Virulence,” Infection and Immunity, Vol. 65, No. 9, 1997, pp. 3539-3546.</mixed-citation></ref><ref id="scirp.26897-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">F. De Bernardis, P. A. Sullivan and A. Cassone, “Aspartyl Proteinases of Candida albicans and Their Role in Pathogenicity,” Medical Mycology, Vol. 39, No. 4, 2001, pp. 303-313. doi:10.1080/714031039</mixed-citation></ref><ref id="scirp.26897-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, A. Hasegawa, F. Debernardis, D. Adriani, G. Pellegrini, A. Cassone, P. L. Fidel, C. G. Haidaris, F. Gigliotti, A. G. Harmsen, S. Fujita, K. Yamamoto, K. Makimura, K. Shibuya, K. Uchida and H. Yamaguchi, “Selected Animal Models: Vaginal Candidosis, Pneumocystis Pneumonia, Dermatophytosis and Trichosporosis,” Medical Mycology, Vol. 36, No. 1, 1998, pp. 129-136.</mixed-citation></ref><ref id="scirp.26897-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">L. Guizhen and T. G. Mitchell, “Rapid Identification of Pathogenic Fungi Directly from Cultures by Using Multiplex PCR,” Journal of Clinical Microbiology, Vol. 40, No. 8, 2002, pp. 2860-2865.  
doi:10.1128/JCM.40.8.2860-2865.2002</mixed-citation></ref><ref id="scirp.26897-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">B. Hube, C. J. Turver, F. C. Odds, H. Heiffert, G. J. Boulnois, H. Kochel and R. Rüchel, “Sequence of the Candida albicans Gene Encoding the Secretory Aspartate Proteinase,” Journal of Medical and Veterinary Mycology, Vol. 29, No. 2 1991, pp. 129-132.  
doi:10.1080/02681219180000221</mixed-citation></ref><ref id="scirp.26897-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">R. J. Wright, A. Carne, A. D. Hieber, I. L. Lamont, G. W. Emerson and A. A. Sullivan, “A Second Gene for a Secreted Aspartate Proteinase in Candida albicans,” Journal of Bacteriology, Vol. 174, No. 23, 1992, pp. 7848- 7853.</mixed-citation></ref><ref id="scirp.26897-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">T. C. White, S. H. Miyasaki and N. Agabian, “Three Distinct Secreted Aspartyl Proteinases in Candida albicans,” Journal of Bacteriology, Vol. 175, No. 19, 1993, pp. 6126-6133.</mixed-citation></ref><ref id="scirp.26897-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">M. Monod, G. Togni, B. Hube and D. Sanglard, “Multiplicity of Genes Encoding Secreted Aspartic Proteinases in Candida Species,” Molecular Microbiology, Vol. 13, No. 2, 1994, pp. 357-368.  
doi:10.1111/j.1365-2958.1994.tb00429.x</mixed-citation></ref><ref id="scirp.26897-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">J. R. Naglik, D. Moyes, J. Makwana, K. Kanzaria, E. Tsichlaki, G. Wendl, A. R. Tappuni, C. A. Rodgers, A. J. Woodman, S. J. Challacombe, M. Schaller and B. Hube, “Quantitative Expression of the Candida albicans Secreted Aspartyl Proteinase Gene Family in Human Oral and Vaginal Candidiasis,” Microbiology, Vol. 154, No. 11, 2008, pp. 3266-3280. doi:10.1099/mic.0.2008/022293-0</mixed-citation></ref><ref id="scirp.26897-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">A. M. Geiger, B. Foxman and B. W. Gillespie, “The Epidemiology of Vulvovaginal Candidiasis among University Students,” American Journal of Public Health, Vol. 85, No. 8, 1995, pp. 1146-1148. 
doi:10.2105/AJPH.85.8_Pt_1.1146</mixed-citation></ref><ref id="scirp.26897-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">M. Geiger and B. Foxman, “Risk Factors for Vulvovaginal Candidiasis: A Case-Control Study among University Students,” Epidemiology, Vol. 7, No. 2, 1996, pp. 182-187. doi:10.1097/00001648-199603000-00013</mixed-citation></ref><ref id="scirp.26897-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, “Vulvovaginitis in Healthy Women,” Comprehensive Therapy, Vol. 25, No. 6, 1999, pp. 335-346. 
doi:10.1007/BF02944280</mixed-citation></ref><ref id="scirp.26897-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">J. D. Sobel, “Epidemiology and Pathogenesis of Recurrent Vulvovaginal Candidiasis,” American Journal of Obstetrics and Gynecology, Vol. 152, No. 7, 1985, pp. 924-935.</mixed-citation></ref><ref id="scirp.26897-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">J. R. Naglik, S. J. Challacombe and B. Hube, “Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis,” Microbiology and Molecular Biology Reviews, Vol. 67, No. 3, 2003, pp. 400-428. 
doi:10.1128/MMBR.67.3.400-428.2003</mixed-citation></ref><ref id="scirp.26897-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">A. R. Colina, F. Aumont, N. Deslauriers, P. Belhumeur and L. de Repentigny, “Evidence for Degradation of Gastrointestinal Mucin by Candida albicans Secretory Aspartyl Proteinase,” Infection and Immunity, Vol. 64, No. 11, 1996, pp. 4514-4519.</mixed-citation></ref><ref id="scirp.26897-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">L. de Repentigny, F. Aumont, K. Bernard and P. Belhumeur, “Characterization of Binding of Candida albicans to Small Intestinal Mucin and Its Role in Adherence to Mucosal Epithelial Cells,” Infection and Immunity, Vol. 68, No. 6, 2000, pp. 3172-3179.  
doi:10.1128/IAI.68.6.3172-3179.2000</mixed-citation></ref><ref id="scirp.26897-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">R. Rüchel, “Cleavage of Immunoglobulins By Pathogenic Yeasts of the Genus Candida,” Microbiological Sciences, Vol. 3, No. 10, 1986, pp. 316-319.</mixed-citation></ref><ref id="scirp.26897-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">B. Hube, “Candida albicans Secreted Aspartyl Proteinases,” Current Topics in Medical Mycology, Vol. 7, No. 1, 1996, pp. 55-59.</mixed-citation></ref><ref id="scirp.26897-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">D. M. Ogrydziak, “Yeast Extracellular Proteases,” Critical Reviews in Biotechnology, Vol. 13, No. 1, 1993, pp. 1-55. doi:10.3109/07388559309069197</mixed-citation></ref><ref id="scirp.26897-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">T. L. Ray and C. D. Payne, “Comparative Production and Rapid Purification of Candida Acid Proteinase from Protein-Supplemented Cultures,” Infection and Immunity, Vol. 58, No. 2, 1990, pp. 508-4514.</mixed-citation></ref><ref id="scirp.26897-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">J. Morschhauser, R. Virkola, T. K. Korhonen and J. Hacker, “Degradation of Human Subendothelial Extracellular Matrix by Proteinase-Secreting Candida albicans,” FEMS Microbiology Letters, Vol. 153, No. 2, 1997, pp. 349-355. 
doi:10.1016/S0378-1097(97)00273-5</mixed-citation></ref><ref id="scirp.26897-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">M. Schaller, M. Bein, C. H. Korting, S. Baur, G. Hamm, M. Monod, S. Beinhauer and B. Hube, “The Secreted Aspartyl Proteinases Sap1 and Sap2 Cause Tissue Damage in an in Vitro Model of Vaginal Candidiasis Based on Reconstituted Human Vaginal Epithelium,” Infection and Immunity, Vol. 71, No. 6, 2003, pp. 3227-3234. 
doi:10.1128/IAI.71.6.3227-3234.2003</mixed-citation></ref><ref id="scirp.26897-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">H. L. Cui and D. L. Wei, “Differential Expression of Candida albicans Secreted Aspartyl Proteinase in Human Vulvovaginal Candidiasis,” Mycoses, Vol. 50, No. 5, 2008, pp. 383-390.</mixed-citation></ref><ref id="scirp.26897-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">G. Newport and N. Agabian, “KEX2 Influences Candida albicans Proteinase Secretion and Hyphal Formation,” The Journal of Biological Chemistry, Vol. 272, No. 46, 1997, pp. 28954-28961. doi:10.1074/jbc.272.46.28954</mixed-citation></ref></ref-list></back></article>